sept. . 23, 2024 19:57 Back to list

Exploring the Properties and Applications of Compound with CAS 2040372-66-5

The compound with the CAS number 204372-66-5 is known as Dasatinib, a potent inhibitor that primarily targets the BCR-ABL fusion protein commonly associated with chronic myeloid leukemia (CML). Initially approved by the U.S. Food and Drug Administration (FDA) in 2006, Dasatinib represented a significant advancement in the treatment of CML, particularly for patients who have developed resistance to first-line therapies such as imatinib.

In addition to its efficacy in treating CML, Dasatinib has also shown promise in addressing other hematological malignancies. For instance, it has been evaluated in certain cases of acute lymphoblastic leukemia (ALL) and has demonstrated effectiveness in patients with Philadelphia chromosome-positive ALL. This versatility makes Dasatinib an important therapeutic agent in the realm of oncology.

cas 40372-66-5

However, as with many medications, the use of Dasatinib comes with potential side effects. Patients may experience a range of reactions, including but not limited to, fatigue, nausea, headache, and more severe risks such as pleural effusion and cardiovascular events. Due to these side effects, continuous monitoring by healthcare professionals is critical to manage any adverse reactions appropriately.

The development of Dasatinib and other TKIs has transformed the landscape of cancer therapy, offering hope to many patients previously faced with limited options. The ongoing research into the effectiveness of Dasatinib, as well as potential combinations with other treatment modalities, continues to expand our understanding of its role in cancer care.

In conclusion, Dasatinib (CAS 204372-66-5) exemplifies how targeted therapies have revolutionized the treatment of malignancies like CML. Its unique mechanism of action, coupled with its adaptability in treating other forms of leukemia, signifies its importance in modern oncology. As research progresses, the potential for improved outcomes for patients facing these challenging diseases remains promising.

Understanding the Composition and Uses of Poly Aluminum Chloride in Water Treatment